| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 384 | 2020 |
| Lineage plasticity in cancer: a shared pathway of therapeutic resistance Á Quintanal-Villalonga, JM Chan, HA Yu, D Pe’er, CL Sawyers, T Sen, ... Nature reviews Clinical oncology 17 (6), 360-371, 2020 | 315 | 2020 |
| Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes M Offin, JM Chan, M Tenet, HA Rizvi, R Shen, GJ Riely, N Rekhtman, ... Journal of Thoracic Oncology 14 (10), 1784-1793, 2019 | 264 | 2019 |
| Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer JM Chan, A Quintanal-Villalonga, VR Gao, Y Xie, V Allaj, O Chaudhary, ... Cancer cell 39 (11), 1479-1496. e18, 2021 | 187 | 2021 |
| Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer CA Wohlhieter, AL Richards, F Uddin, CH Hulton, À Quintanal-Villalonga, ... Cell reports 33 (9), 2020 | 139 | 2020 |
| Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation A Quintanal-Villalonga, H Taniguchi, YA Zhan, MM Hasan, SS Chavan, ... Cancer discovery 11 (12), 3028-3047, 2021 | 77 | 2021 |
| FGFR1 cooperates with EGFR in lung cancer oncogenesis, and their combined inhibition shows improved efficacy A Quintanal-Villalonga, S Molina-Pinelo, C Cirauqui, L Ojeda-Márquez, ... Journal of Thoracic Oncology 14 (4), 641-655, 2019 | 56 | 2019 |
| Epigenetics of lung cancer: a translational perspective Á Quintanal-Villalonga, S Molina-Pinelo Cellular Oncology 42 (6), 739-756, 2019 | 52 | 2019 |
| Targeting lysine-specific demethylase 1 rescues major histocompatibility complex class I antigen presentation and overcomes programmed death-ligand 1 blockade resistance in SCLC EM Nguyen, H Taniguchi, JM Chan, YA Zhan, X Chen, J Qiu, ... Journal of Thoracic Oncology 17 (8), 1014-1031, 2022 | 39 | 2022 |
| Multiple Vibrio fischeri genes are involved in biofilm formation and host colonization A Chavez-Dozal, D Hogan, C Gorman, A Quintanal-Villalonga, ... FEMS microbiology ecology 81 (3), 562-573, 2012 | 34 | 2012 |
| The FGFR4-388arg variant promotes lung cancer progression by N-cadherin induction Á Quintanal-Villalonga, L Ojeda-Márquez, Á Marrugal, P Yagüe, ... Scientific reports 8 (1), 2394, 2018 | 32 | 2018 |
| Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics CH Hulton, EA Costa, NS Shah, A Quintanal-Villalonga, G Heller, ... Nature cancer 1 (3), 359-369, 2020 | 31 | 2020 |
| The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer A Chow, FZ Uddin, M Liu, A Dobrin, BY Nabet, L Mangarin, Y Lavin, ... Immunity 56 (1), 93-106. e6, 2023 | 29 | 2023 |
| Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation A Quintanal-Villalonga, H Taniguchi, YA Zhan, MM Hasan, SS Chavan, ... Journal of Hematology & Oncology 14, 1-19, 2021 | 28 | 2021 |
| Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade JA Pai, MD Hellmann, JL Sauter, M Mattar, H Rizvi, HJ Woo, N Shah, ... Cancer Cell 41 (4), 776-790. e7, 2023 | 26 | 2023 |
| Rb tumor suppressor in small cell lung cancer: combined genomic and IHC analysis with a description of a distinct Rb-proficient subset CA Febres-Aldana, JC Chang, R Ptashkin, Y Wang, E Gedvilaite, ... Clinical Cancer Research 28 (21), 4702-4713, 2022 | 26 | 2022 |
| Rlf–Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer M Ciampricotti, T Karakousi, AL Richards, À Quintanal-Villalonga, ... Cancer discovery 11 (12), 3214-3229, 2021 | 25 | 2021 |
| MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma I Ferrer, Á Quintanal-Villalonga, S Molina-Pinelo, JM Garcia-Heredia, ... Journal of Experimental & Clinical Cancer Research 37, 1-13, 2018 | 22 | 2018 |
| IL-11 and CCL-1: novel protein diagnostic biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid (BALF) MD Pastor, A Nogal, S Molina-Pinelo, A Quintanal-Villalonga, ... Journal of Thoracic Oncology 11 (12), 2183-2192, 2016 | 21 | 2016 |
| Inhibition of XPO1 sensitizes small cell lung cancer to first-and second-line chemotherapy A Quintanal-Villalonga, H Taniguchi, Y Hao, A Chow, YA Zhan, ... Cancer research 82 (3), 472-483, 2022 | 19 | 2022 |
Charles RudinChief, Thoracic Oncology, Memorial Sloan Kettering Cancer CenterGeverifieerd e-mailadres voor mskcc.org
